Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Driving Business Growth in B2B Marketing: The Game-Changing Impact of the Creator Economy

B2B brands in the healthcare industry are increasingly leveraging creator economy partnerships to build credibility and drive revenue growth. The article explores how thought leaders and content creators can serve as strategic assets in crowded B2B marketplaces. Creator-led strategies are emerging as a differentiator for healthcare organizations seeking authentic audience engagement.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Experts Talk on MarketScale.

By Experts Talk · BlitzmetricsCreator EconomyDavid KempDennis Yu
Share

Key takeaways

01

B2B healthcare brands are partnering with creators to establish credibility in competitive markets.

02

The creator economy is reshaping how B2B companies approach demand generation and revenue growth.

03

Authentic creator content can accelerate trust-building with healthcare decision-makers and buyers.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Influencer marketing is no longer just for consumer brands. In a report titled Influencing Business: The Global Rise of B2B Influencer Marketing, Ogilvy estimates that the global market size has expanded over 20 times since 2016! And with the creator economy projected to reach $500 billion by 2027, businesses are taking note. Social platforms like YouTube, Instagram, and TikTok, boasting nearly 5 billion monthly active users, have fueled this rise of the creator economy. The question is, how can the B2B marketing sector leverage this trend to build trust and drive business impact?

And with the creator economy projected to reach $500 billion by 2027, businesses are taking note.

In the latest episode of Experts Talk, host Gabrielle Bejarano dives into this topic with guests David Kemp, Healthcare Lead at MarketScale, and Dennis Yu, CTO of BlitzMetrics. They explore the evolving landscape of influencer marketing and its growing importance in the B2B marketing sector.

Key discussion points include:

– The exponential growth and potential of influencer marketing in B2B.

– The importance of selecting credible influencers to build trust.

– How leveraging employee influencers can be a game-changer.

David Kemp's career spans from coaching college basketball to aiding major healthcare systems with ICD-10 transitions. Kemp now hosts the Highway to Health podcast series and leads the healthcare vertical at MarketScale.

Dennis Yu is the CEO of BlitzMetrics, a digital marketing company that collaborates with schools to train young adults in the field. He has extensive experience in managing high-profile campaigns for clients like The Golden State Warriors and Nike, and is also an internationally recognized lecturer who has spoken at over 730 events across 17 countries.

Experts Talk

Part of this channel

Experts Talk

Industry experts debate the ideas that drive B2B decisions.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

ET
Experts Talk

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

The FDA approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara for multiple inflammatory diseases, which means it may be substituted without consulting the prescriber, subject to state pharmacy laws. A Springer analysis reported 26 interchangeable biosimilars approved since 2020 and said average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024. The operational pressure shifts to formulary, payer, and specialty pharmacy workflow design.

  • 01Interchangeability is becoming the default ask, not an afterthought: Springer found 17 of 26 approvals pursued interchangeability concurrently, which changes how buyers should time contracting and conversions.
  • 02Springer reported average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024, which can compress planning windows for monitoring and implementation.
  • 03A new interchangeable ustekinumab option means the hard work is no longer clinical, it is operational: NDC mapping, EMR preference lists, substitution rules by state, and patient communications decide whether savings show up.

Sep 8, 2026

AAO-HNSF hearing loss guideline moves audiograms and amplification into primary care

AAO-HNSF’s new age-related hearing loss guideline calls for screening adults starting at age 50 and escalating to otoscopy, audiogram, and appropriately fit amplification. It shifts hearing loss from “patient complaint” to a routine primary-care workflow. The pressure shows up in audiology capacity, referral design, and documentation standards.

  • 01Screening at age 50 becomes a repeatable workflow, so capacity planning shifts from episodic ENT referrals to steady primary-care volume, especially where annual wellness visits are a dominant access point.
  • 02The guideline’s escalation sequence, screen, otoscopy, audiogram, amplification, then cochlear implant candidacy evaluation, creates a measurable funnel that health systems can instrument in the EHR and manage like any other pathway.
  • 03Asymmetric loss remains a separate trigger for MRI in many settings, and 2026 pre-proof work using NHANES and SEER highlights why imaging criteria choices can swing scan volume, a budgeting and radiology access issue, not a clinical footnote.

Sep 7, 2026

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

Accenture will keep supporting Australia’s My Health Record under a new three-year contract. ADHA is moving the platform to a multi-supplier operating model. The shift raises questions about shared integration discipline, tooling, and accountability when changes hit production.

  • 01Multi-supplier delivery is spreading across national-scale health platforms, as ADHA's My Health Record shift shows, moving risk from vendor selection to integration, runbooks, and accountability.
  • 02GenAI model upgrades are arriving with healthcare-specific claims, but the procurement work moves to evidence, safety controls, and monitoring once models sit inside clinical workflows.
  • 03Embedded AI expands the cyber asset inventory problem: if teams cannot discover the AI components across endpoints and devices, they cannot reliably secure or audit them.

Sep 7, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

ET
Experts Talk

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512